Sotera Health Company
Financials
Valuation Metrics
Sotera Health Company's Market Cap is $5.34B. At end of 2025 it was $5.01B. Ranked #1297 of 3,121 in US market (top 42%), #439 of 1,463 on NASDAQ (top 30%), #81 of 205 in Health Care Equipment & Services (top 40%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $5.34B | US#1,297/3,121 Sec#81/205 |
| Revenue | $1.22B | US#1,769/3,121 Sec#109/205 |
| Net Income | $163M | US#1,394/3,121 Sec#68/205 |
| Total Assets | $3.31B | US#1,749/3,121 Sec#83/205 |
| Net Assets | $666M | US#2,051/3,121 Sec#108/205 |
| Employees | 3,000 | US#1,476/3,121 Sec#104/205 |
| Value | ||
| P/E | 32.67x | US#1,663/3,121 Sec#67/205 |
| P/B | 8.02x | US#2,531/3,121 Sec#160/205 |
| PEG | 0.06x | US#138/3,121 Sec#6/205 |
| P/S | 4.39x | US#2,189/3,121 Sec#145/205 |
| EV/EBITDA | 13.45x | US#1,364/3,121 Sec#49/205 |
| FCF Yield | 2.11% | US#2,025/3,121 Sec#120/205 |
| Profitability | ||
| ROE | 24.56% | US#422/3,121 Sec#20/205 |
| ROA | 4.94% | US#1,058/3,121 Sec#67/205 |
| Op. Margin | 36.24% | US#369/3,121 Sec#4/205 |
| Revenue Growth | 8.15% | US#1,463/3,121 Sec#103/205 |
| Earnings Growth | 580.51% | US#61/3,121 Sec#4/205 |
| Financial Health | ||
| Debt Ratio | 396.78% | US#2,269/3,121 Sec#177/205 |
| Total Debt | $2.27B | US#1,112/3,121 Sec#52/205 |
| FCF | $113M | US#1,689/3,121 Sec#98/205 |
| Cash | $357M | US#1,295/3,121 Sec#75/205 |
| Current Ratio | 2.80x | US#868/3,121 Sec#87/205 |
| Net Debt/EBITDA | 3.54x | US#1,744/3,121 Sec#110/205 |
| Dividend | ||
| Div. Growth | 240.16% | US#38/3,121 Sec#3/205 |
| Performance | ||
| 1Y Return | 17.28% | US#1,273/3,121 Sec#96/205 |
| 1M Return | -1.42% | US#688/3,121 Sec#76/205 |
| From 52W High | -5.64% | US#271/3,121 Sec#32/205 |
| 1Y MDD | -32.14% | US#1,567/3,121 Sec#76/205 |
| Trading | ||
| Volume | 5,121,899 shares | US#867/3,121 Sec#49/205 |
| Trading Value | $96M | US#1,496/3,121 Sec#107/205 |
| Per Share | ||
| EPS | $0.57 | US#1,856/3,121 Sec#102/205 |
| BPS | $2.33 | US#2,551/3,121 Sec#168/205 |
Company Info
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.